LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC
PHARMAnetwork - pharmaceutical CDMO business and contract pharma news - PHARMAnetwork magazine
Ampersand Capital Partners på LinkedIn: U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into…
Alliance Pharma has acquired Drug Development Solutions and attracted KKR as a backer
Ampersand Capital Partners Invests in Syft Technologies | citybiz
À propos de nous - Nexelis, a Q² Solutions Company
Ampersand Portfolio Company U.S. Alliance Pharma Acquires U.K.-based LGC's Drug Development Solutions (DDS) Business | Ampersand Capital
Press release under embargo until Tuesday 17 May 12.00 BST Ampersand-backed Alliance Pharma to acquire LGC's Drug Development
In the News
News - Alliance Pharma | Feng Li
News - Alliance Pharma | Ryan Klein
Alliance in the News - Ampersand
Ampersand backs Alliance and plans growth - BioProcess InsiderBioProcess International
Alliance Pharma Expands Bioanalytical Services | Contract Pharma
Alliance Pharma Acquires Drug Development Solutions - PHARMAnetwork news
Ampersand-backed Alliance Pharma to acquire LGC's Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder | Ampersand Capital
LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC
Ampersand Invests in Alliance Pharma, Leading Bioanalytical CRO
Alliance Pharma to acquire LGC's Drug Development Solutions business, with KKR as joint shareholder - Bioanalysis Zone
LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC
RETOURS DES ANCIENS
Branden Berns on LinkedIn: It's official. The new year has been an excellent occasion to reflect on… | 114 comments
LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC
About us | Alliance Pharma
News - Alliance Pharma | Ryan Klein
Resolian on Twitter: "Ampersand Invests in Alliance Pharma, Leading Bioanalytical CRO https://t.co/XKBmAYA97D" / Twitter
